XML 72 R41.htm IDEA: XBRL DOCUMENT v3.22.1
Note 1 - Nature of the Business - Schedule of Subsidiaries (Details)
Dec. 31, 2021
BeyondSpring Pharmaceuticals Inc. [Member]  
Equity method investment, ownership percentage 100.00%
SEED Therapeutics Inc. [Member]  
Equity method investment, ownership percentage 58.97%
BeyondSpring Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
SEED Technology Limited [Member]  
Equity method investment, ownership percentage 57.97%
BeyondSpring HK [Member]  
Equity method investment, ownership percentage 100.00%
SEED Therapeutics US, Inc. [Member]  
Equity method investment, ownership percentage 58.97%
Wanchun Biotechnology Limited [Member]  
Equity method investment, ownership percentage 100.00%
Wanchun Biotechnology (Shenzhen) Ltd. [Member]  
Equity method investment, ownership percentage 100.00%
Dalian Wanchunbulin Pharmaceuticals Ltd. (“Wanchunbulin”) [Member]  
Equity method investment, ownership percentage 57.97%
BeyondSpring Pharmaceuticals Australia PTY Ltd. (“BeyondSpring Australia”) [Member]  
Equity method investment, ownership percentage 100.00%
Beijing Wanchun Pharmaceutical Technology Ltd. [Member]  
Equity method investment, ownership percentage 57.97%